• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

126
118
93
92
80

COUNTRY

73
33
28
23
19

PRICE

515
564
594
902

PUBLISHED

1
32
49
902

PRODUCT TYPE

488
398
14
1
1

In Vitro Diagnostics

A core activity in so many areas like medicine, life science, pharmaceuticals – in clinical, industrial and research settings – in vitro diagnostics (IVD) is a major market with big technological and commercial prospects and is forecast to grow at a CAGR of 6.55 percent over the period 2011-2015. The main growth drivers are the increasing demand for biomarker-based tests worldwide and an increased adoption of DNA probe-based diagnostics.

Our wealth of detailed and insightful reports covers a wide variety of topics within the IVD sphere; these include immunochemistry, molecular diagnostics, point-of-care testing, microbiology, hematology, immunoassays and infectious immunology.

Make your move based on the latest knowledge and data in this dynamic field by keeping track of investment opportunities, scientific developments, new products and technologies, market shares, key players and much more.

Hundreds of companies operating in today’s market are featured in our publications, including top global players such as Abbott Laboratories, bioMerieux SA, Beckman Coulter, Becton Dickinson and Company, Hoffmann-La Roche, and Siemens Healthcare, as well as niche players and new, fast-growing companies. Show Less
Read more

PRODUCT TITLE

In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020

In vitro diagnostics are tests that diagnose and prevent diseases, conditions or infections. IVD tests are performed outside body in an artificial environment on samples such as blood, urine, tissue...

August 2014
FROM
2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations 2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. “2014 Market Segmentation Analysis of the European Cancer Diagnostics...

July 2014
FROM
2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs 2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs - Product Thumbnail Image

2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. “2014 Market Segmentation Analysis of the UK Cancer Diagnostics...

July 2014
FROM
2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs 2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs - Product Thumbnail Image

2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. “2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics...

July 2014
FROM
2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs 2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs - Product Thumbnail Image

2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. “2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics...

July 2014
FROM
2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations 2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.“2014 Market Segmentation Analysis of the US Cancer Diagnostics...

July 2014
FROM
2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs 2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs - Product Thumbnail Image

2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. “2014 Market Segmentation Analysis of the French Cancer Diagnostics...

July 2014
FROM
2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs 2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs - Product Thumbnail Image

2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. “2014 Market Segmentation Analysis of the Italian Cancer Diagnostics...

July 2014
FROM
2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. “2014 Market Segmentation Analysis of the Global Cancer Diagnostics...

July 2014
FROM
2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs and Physician Offices 2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs and Physician Offices - Product Thumbnail Image

2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs and Physician Offices

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. “2014 Market Segmentation Analysis of the German Cancer Diagnostics...

July 2014
FROM
European Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) European Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) - Product Thumbnail Image

European Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack)

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. This new five-country study from the author contains 495 pages,...

July 2014
FROM
France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) - Product Thumbnail Image

France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack)

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new study from the author contains 407 pages, and is designed to...

July 2014
FROM
U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) - Product Thumbnail Image

U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack)

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new study from the author contains 408 pages, and is designed to...

July 2014
FROM
Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) - Product Thumbnail Image

Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack)

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new study from the author contains 402 pages, and is designed to...

July 2014
FROM
Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) - Product Thumbnail Image

Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack)

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new study from the author contains 410 pages, and is designed to...

July 2014
FROM
Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) - Product Thumbnail Image

Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack)

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. This new seven-country study from the author contains 570 pages,...

July 2014
FROM
Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) - Product Thumbnail Image

Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack)

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new study from the author contains 407 pages, and is designed to...

July 2014
FROM
Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) - Product Thumbnail Image

Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack)

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new study from the author contains 407 pages, and is designed to...

July 2014
FROM
U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack) - Product Thumbnail Image

U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape (Datapack)

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new study from the author contains 430 pages, and is designed to...

July 2014
FROM
Drugs of Abuse Testing Markets (Lab-Based, Professional POC, Home, Employment, Criminal Justice Markets) Drugs of Abuse Testing Markets (Lab-Based, Professional POC, Home, Employment, Criminal Justice Markets) - Product Thumbnail Image

Drugs of Abuse Testing Markets (Lab-Based, Professional POC, Home, Employment, Criminal Justice Markets)

Drugs of Abuse is an important growth category in IVD testing with competitive participation by top IVD vendors for market share. Healthcare professionals, employers, criminal justice personnel, and...

July 2014
FROM
Loading Indicator

Our Clients

Our clients' logos